|
|
|
|
| The rapid advance of ADCs has tested the fine balance between speed to IND and process development that stands up to the rigors of scale-up and transfer. Explore the processes leading ADC developers are employing to mitigate manufacturing-scale risk, and how automation and artificial intelligence are beginning to inform their work. Join Bioprocess Online Live for this interactive discussion. Registration is free thanks to the support of Thermo Fisher Scientific. |
|
|
FOCUS ON UPSTREAM MANUFACTURING |
|
|
|
By Tyler Menichiello, contributing editor | Experts from Eli Lilly, NervGen, and Piramal Pharma Solutions discuss the myriad of ways peptide manufacturing can be improved, drawing on years of industry experience and insight. | |
|
|
|
|
| Efficient Cell Banking In Seed Train Intensification | Q&A | By Khalil Essani, Single Use Support | Gain insight into seed train intensification in upstream development, cell banking, and the challenges of cryopreservation processes from Khalil Essani, the Product Line Manager at Single Use Support. |
|
|
|
|
|
|
|
|
| BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty | Live from the 2025 JP Morgan Healthcare Conference, The Business of Biotech dives into a game-changing approach to biotech financing with XOMA Royalty’s Owen Hughes & Brad Sitko. They break down their royalty aggregation model, how it mitigates risk, and why it’s an alternative to equity-based funding. Don’t miss this insightful conversation on the future of biotech capital access! |
|
|
UPSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
